Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.

Literature DB >> 1850041

Immunologic priming with recombinant hepatitis A virus capsid proteins produced in Escherichia coli.

Abstract

Hepatitis A virus capsid proteins (VP0, VP3, and VP1) have been synthesized in Escherichia coli for use in antigenic and immunogenic analyses. Rabbits immunized with each of these individual recombinant capsid proteins developed a rapid neutralizing antibody response when subsequently challenged with a subimmunogenic dose of whole virus.

Entities: Species

Mesh：

Substances：

Year: 1991 PMID： 1850041 PMCID： PMC240628

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

18 in total

1. Preparative elution of proteins blotted to Immobilon membranes.

Authors: B Szewczyk; D F Summers
Journal: Anal Biochem Date: 1988-01 Impact factor: 3.365

Review 2. Type A viral hepatitis. New developments in an old disease.

Authors: S M Lemon
Journal: N Engl J Med Date: 1985-10-24 Impact factor: 91.245

3. Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors: H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal: J Immunol Date: 1987-04-01 Impact factor: 5.422

4. Structure of the hepatitis A virion: peptide mapping of the capsid region.

Authors: C M Wheeler; B H Robertson; G Van Nest; D Dina; D W Bradley; H A Fields
Journal: J Virol Date: 1986-05 Impact factor: 5.103

5. Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site.

Authors: J V Hughes; L W Stanton; J E Tomassini; W J Long; E M Scolnick
Journal: J Virol Date: 1984-11 Impact factor: 5.103

6. Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization.

Authors: S M Lemon; L N Binn
Journal: Infect Immun Date: 1983-10 Impact factor: 3.441

7. Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures.

Authors: S M Lemon; L N Binn; R H Marchwicki
Journal: J Clin Microbiol Date: 1983-05 Impact factor: 5.948

8. Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.

Authors: V Gauss-Müller; M Q Zhou; K von der Helm; F Deinhardt
Journal: J Med Virol Date: 1990-08 Impact factor: 2.327

9. Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.

Authors: J M Johnston; S A Harmon; L N Binn; O C Richards; E Ehrenfeld; D F Summers
Journal: J Infect Dis Date: 1988-06 Impact factor: 5.226

10. Genomic heterogeneity among human and nonhuman strains of hepatitis A virus.

Authors: S M Lemon; S F Chao; R W Jansen; L N Binn; J W LeDuc
Journal: J Virol Date: 1987-03 Impact factor: 5.103

5 in total

1. The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into viruslike particles.

Authors: P L Winokur; J H McLinden; J T Stapleton
Journal: J Virol Date: 1991-09 Impact factor: 5.103

2. Recombinant vaccinia viruses expressing hepatitis A virus structural polypeptides: detection of an anti-VP0 response in convalescent-phase sera.

Authors: P Karayiannis; S O'Rourke; R Watts; J Waters; V Hill; W F Carman; H C Thomas
Journal: Clin Diagn Lab Immunol Date: 1995-11